Manufacturer record
Rivpra FormulationPvt.Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Rivpra FormulationPvt.Ltd (Uttarakhand) was declared Not of Standard Quality in May 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: TCV- 2303003, Amoxycillin & Potassium Clavulanate Tablets I.P.. (exp Feb 2025). RDTL Guwahati (CDSCO lab) found it not of standard quality: The sample does not conform to I.P. with respect to the test for Assay. Listed in the May 2024 alert.
Records by type
1 record linked to Rivpra FormulationPvt.Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amoxycillin & Potassium Clavulanate Tablets I.P.. | Batch TCV- 2303003Mfg Mar 2023 · Exp Feb 2025 | The sample does not conform to I.P. with respect to the test for Assay.Assay | RDTL GuwahatiCDSCO lab | May 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.